Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thida, Mya | - |
dc.contributor.author | Kim, Dae Won | - |
dc.contributor.author | Thi Thu Thuy Tran | - |
dc.contributor.author | Minh Quan Pham | - |
dc.contributor.author | Lee, Heesu | - |
dc.contributor.author | Kim, Inki | - |
dc.contributor.author | Lee, Jae Wook | - |
dc.date.accessioned | 2024-01-20T05:01:38Z | - |
dc.date.available | 2024-01-20T05:01:38Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2016-02-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/124411 | - |
dc.description.abstract | Gambogic acid (GA), a natural product with a xanthone structure, has a broad range of anti-proliferative effects on cancer cell lines. We evaluated GA for its cytotoxic effects on T98G glioblastoma cells. GA exhibited potent anti-proliferative activity and induced apoptosis in T98G glioblastoma cells in a dose-dependent manner. Incubation of cells with GA revealed apoptotic features including increased Bax and AIF expression, cytochrome c release, and cleavage of caspase-3, -8, -9, and PARP, while Bcl-2 expression was downregulated. Furthermore, GA induced reactive oxygen species (ROS) generation in T98G cells. Our results indicate that GA increases Bax- and AIF-associated apoptotic signaling in glioblastoma cells. (C) 2015 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | CYCLE ARREST | - |
dc.subject | INHIBITION | - |
dc.subject | PHOSPHORYLATION | - |
dc.subject | TEMOZOLOMIDE | - |
dc.subject | TARGET | - |
dc.title | Gambogic acid induces apoptotic cell death in T98G glioma cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2015.11.043 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.26, no.3, pp.1097 - 1101 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 26 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1097 | - |
dc.citation.endPage | 1101 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000368797600079 | - |
dc.identifier.scopusid | 2-s2.0-84979197943 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CYCLE ARREST | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | TEMOZOLOMIDE | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordAuthor | Gambogic acid | - |
dc.subject.keywordAuthor | Reactive oxygen species (ROS) | - |
dc.subject.keywordAuthor | Glioblastoma | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Anticancer | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.